To assist members with a variety of Department of Health and Human Services’ (HHS) No Surprises Act resources that have recently been updated, CHA will host a webinar on Feb. 9. During the webinar, Amanda Hayes-Kibreab, partner at Kings-Spalding, will share insights, and:
Join Amanda Hayes-Kibreab, partner, and Alana Broe, associate at King & Spalding, as they share insights on the No Surprises Act.
CHA will host a webinar at 10 a.m. Nov. 9 on new post-acute care reimbursement rules.
The 2023 Medicare rules for post-acute care reimbursement have been finalized, and CHA has the information you need.
To assist members in navigating the No Surprises Act final rule, CHA will host a complimentary webinar from 11 a.m. to noon (PT) on Sept. 30.
Join CHA’s Chad Mulvany and Amanda Hayes-Kibreab, partner at King & Spalding, as they provide insight and guidance for members navigating the No Surprises Act final rule.
As previously announced in CHA News, the California Department of Health Care Services (DHCS) and its Medi-Cal Rx contractor Magellan will reinstate pharmacy claim edits and Reject Code 88 for diagnosis and drug utilization review requirements on July 22.
Livanta, Medicare’s national claims review contractor, has launched the Livanta Claims Review Advisor — a monthly online educational resource for medical coders, billing, financial and revenue cycle personnel, clinical documentation improvement specialists, utilization review coordinators, case managers, compliance officers, physicians, and other practitioners.
On Oct. 20, the Food and Drug Administration amended the emergency use authorization for COVID-19 vaccines to allow booster doses for the Moderna and Johnson & Johnson vaccines. The Centers for Medicare & Medicaid Services has released new billing coding for the Johnson & Johnson and Moderna COVID-19 vaccine booster shots. Current billing codes, payment allowances, and effective dates are available online.
The Centers for Medicare & Medicaid Services has announced will pay the full cost of the Pfizer-BioNTech COVID-19 booster shots to providers without cost-sharing for Medicare, Medicaid, and the Children’s Health Insurance Program beneficiaries.